Blue Cross Blue Shield of Wyoming welcomes the arrival of safe and effective vaccines as a key component in the national and local COVID-19 response. BCBSWY will waive all cost-sharing for any fees charged to administer the vaccines.
Each vaccine has its own code and administration code. Since the Pfizer and Moderna vaccines require two doses, each vaccine has two administration codes to indicate which dose was administered. Please see the table below for coding guidance including the Johnson & Johnson vaccine.
|Manufacturer||Vaccine Code||Description||Administration Codes|
|Pfizer||91300||Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3mL dosage, diluent reconstituted, for intramuscular use||• 0001A (1st dose)
• 0002A (2nd dose)
• 0003A (3rd dose)
• 0004A (booster)
|Moderna||91301||Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 100 mcg/0.5mL dosage, for intramuscular use
|• 0011A (1st dose)
• 0012A (2nd dose)
• 0013A (3rd dose)
|Janssen/Johnson& Johnson||91303||Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, DNA, spike protein, adenovirus type 26 (Ad26) vector, preservative free, 5×1010 viral particles/0.5mL dosage, for intramuscular use||• 0031A (single dose)|
|Moderna (Booster)||91306||Severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) (coronavirus disease [COVID-19]) vaccine, mRNALNP, spike protein, preservative free, 50 mcg/0.25 mL dosage, for intramuscular use||0064A|
|Pfizer (Pediatric)||91307||Severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) (coronavirus disease [COVID-19]) vaccine, mRNALNP, spike protein, preservative free, 10 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation, for intramuscular use||0071A: First dose
0072A: Second dose
Inpatient Hospital Prior Authorizations & Concurrent Review Update
Beginning April 1st, 2021 all hospital inpatient prior authorizations and concurrent reviews for BCBSWY members should be submitted through the Availity portal. To assist our providers with this transition, BCBSWY will be offering two training sessions this March. To register please contact Provider Relations at email@example.com. If you are unable to attend any of these trainings let us know and we can set up an individual session. For more information on prior authorization requirements please visit: https://www.bcbswy.com/providers/preadmin/.
March 16th, 2:00 pm
March 18th, 2:00 pm
Is your practice offering telemedicine?
BCBSWY would like to know if your practice offers telemedicine visits to your patients. If so, please complete this short form. We will use this information to update the BCBSWY Provider Directory to let patients know you offer this service.
BCBSWY Mailing Address:
PO Box 2266, Cheyenne, WY 82003-2266
Blue Cross Blue Shield of Wyoming is an independent licensee of the Blue Cross and Blue Shield Association